UK competition regulator looking into $39 bln
Britain's competition regulator is reviewing AstraZeneca's (AZN.L) $39 billion buyout of U.S.-based Alexion (ALXN.O)
Please be informed that a specific anonymous source is attempting a cyber-attack to damage the reputation of World Economic Magazine. They might attempt to access your personal or professional email under the guise of making untrue accusations against our company via email, the internet, etc. You are urged to use extreme caution when receiving such emails because these statements are false and fraudulent.
Please note that we never owed any monetary dues to any party whatsoever. Any agency or source claiming otherwise, is doing so solely with a deceitful intention and is a part of fraudulent activities
Britain's competition regulator is reviewing AstraZeneca's (AZN.L) $39 billion buyout of U.S.-based Alexion (ALXN.O)
Here's what you need to know about the coronavirus right now.
Japanese tycoon Masayoshi Son warned of significant dangers around holding the Olympics in Tokyo,
India’s Cadila Healthcare (CADI.NS) is aiming to triple monthly production of a COVID-19 vaccine
Leaders of the world's largest economies kicked off a global health summit on Friday,
In early 2020, as a new deadly coronavirus began spreading around the world, Pfizer
People in the world's leading economies remain overwhelmingly nervous about returning to life as
Waiving intellectual property rights for COVID-19 vaccines will not be enough to narrow the
The International Olympic Committee (IOC) reassured an anxious Japan on Wednesday that the Tokyo
A Spanish study on mixing COVID-19 vaccines has found that giving a dose of